Kodiak Sciences KOD
NASDAQ KOD
$94.45 -4.01 (-4.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kodiak Sciences (KOD) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Kodiak Sciences' Return on Capital Employed [ROCE] came in at -107.78% for Q2 2026, down 23.58 percentage points from -84.20% a year earlier and down 23.57 percentage points from the prior quarter.

Analysis

Kodiak Sciences (KOD) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Kodiak Sciences' Return on Capital Employed [ROCE] was -78.65%, down 29.72 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -58.70 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -48.93% in FY2024 (+3.27 pp), -52.20% in FY2023 (-5.62 pp), -46.58% in FY2022 (-17.58 pp) and -28.99% in FY2021 (-9.04 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -114.44% (Q3 2025) to -23.91% (Q3 2021).
  • Year-over-year, Return on Capital Employed [ROCE] has declined for six consecutive quarters, with an average year-over-year change of -22.10 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2024 (a gain of 4.50 percentage points), and the weakest in Q3 2025 (a drop of 58.24 percentage points).
  • Business Quant data shows KOD's Return on Capital Employed [ROCE] at -84.20% (Q1 2026), -97.96% (Q4 2025) and -114.44% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Kodiak Sciences 5.93 Bn 5.93 Bn - -107.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -107.78%
Mar 31, 2026 -84.20%
Dec 31, 2025 -97.96%
Sep 30, 2025 -114.44%
Jun 30, 2025 -84.20%
Mar 31, 2025 -69.92%
Dec 31, 2024 -56.87%
Sep 30, 2024 -56.20%
Jun 30, 2024 -53.38%
Mar 31, 2024 -57.56%
Dec 31, 2023 -58.78%
Sep 30, 2023 -57.85%
Jun 30, 2023 -57.88%
Mar 31, 2023 -54.78%
Dec 31, 2022 -53.11%
Sep 30, 2022 -52.43%
Jun 30, 2022 -46.69%
Mar 31, 2022 -38.99%
Dec 31, 2021 -30.82%
Sep 30, 2021 -23.91%
API Access

Kodiak Sciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KOD&period=max&api_key=YOUR_API_KEY